Portolan Capital Management, LLC Bio Rad Laboratories, Inc. Transaction History
Portolan Capital Management, LLC
- $1.32 Billion
- Q4 2024
A detailed history of Portolan Capital Management, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Portolan Capital Management, LLC holds 30,586 shares of BIO stock, worth $7.77 Million. This represents 0.76% of its overall portfolio holdings.
Number of Shares
30,586
Previous 21,900
39.66%
Holding current value
$7.77 Million
Previous $7.33 Million
37.12%
% of portfolio
0.76%
Previous 0.58%
Shares
30 transactions
Others Institutions Holding BIO
# of Institutions
478Shares Held
19.2MCall Options Held
15.7KPut Options Held
11.5K-
Vanguard Group Inc Valley Forge, PA1.92MShares$488 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$394 Million0.01% of portfolio
-
Wealthfront Advisers LLC1.04MShares$265 Million0.29% of portfolio
-
Veritas Asset Management LLP977KShares$248 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$190 Million0.06% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.26B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...